DZ Bank
VRTX icon

DZ Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

DZ Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,000
Closed -$7.89M – 1081
2022
Q1 		$7.89M Buy
+30,000
New +$7.12M 0.01% 402

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

DZ Bank's VRTX Position: Q1 2026 in Review

DZ Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 55% in Q1 2026, selling an estimated $205M and leaving 364,513 shares worth $163M. The position accounts for 0.14% of the portfolio, ranked #116.

DZ Bank first reported a position in VRTX in Q4 2017 and has held it in 34 quarters since. The position peaked at $563M in Q3 2020. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • DZ Bank held 364,513 shares of Vertex Pharmaceuticals worth $163M as of Q1 2026.
  • DZ Bank sold 439,260 Vertex Pharmaceuticals shares in Q1 2026, an estimated $205M.
  • Vertex Pharmaceuticals made up 0.14% of DZ Bank's portfolio in Q1 2026, its #116 holding.
  • DZ Bank first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 34 quarters since.
  • DZ Bank's Vertex Pharmaceuticals position peaked at $563M in Q3 2020.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.